Skip to main content
logo
Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
77.60
+0.80 (1.04%)
Sep 8, 2026, 12:48 PM CST

Steminent Biotherapeutics Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6,1884,0051,284---
Market Cap Growth
143.17%211.83%----
Enterprise Value
5,3663,9241,036---
Last Close Price
76.8059.2021.14---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
6.136.663.62---
P/TBV Ratio
6.146.683.65---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.070.120.180.150.340.08
Net Debt / Equity Ratio
-0.81-0.71-0.43-0.76-0.60-0.86
Net Debt / EBITDA Ratio
4.352.750.972.911.022.94
Net Debt / FCF Ratio
4.603.040.682.651.373.79
Asset Turnover
---0.000.000.01
Inventory Turnover
0.270.060.620.361.380.37
Quick Ratio
20.8913.116.8711.716.3810.28
Current Ratio
21.8513.587.4312.076.6810.79
Return on Equity (ROE)
-31.72%-36.41%-37.45%-39.37%-41.92%-107.40%
Return on Assets (ROA)
-17.62%-19.12%-19.69%-19.81%-23.83%-24.89%
Return on Capital Employed (ROCE)
-19.70%-26.30%-40.10%-23.70%-46.40%-29.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.30%-4.35%-12.36%---
FCF Yield
-2.89%-3.50%-17.64%---
Buyback Yield / Dilution
-20.73%-5.49%-15.42%-8.84%-26.27%-17.57%